Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1046 per EA under NDC 60687080121. Its NADAC has been published 125 times since Apr 3, 2024.
FDA first approved this application on Feb 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
American Health PackagingNDC
60687080121
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078888FDA Approved
2/7/2014
TE Code
AB
On Market Since
2/21/2024
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 125 times since Apr 3, 2024, and over the history we have for it it has declined 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1046 per EA |
|---|---|
| All-time high | $0.1444 (Apr 10, 2024) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1046 |
| Median price | $0.1167 |
| Average price | $0.1140 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 125 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by American Health Packaging, is $0.1046 per EA (NDC 60687080121), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 27.6%. It has been tracked across 125 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Apr 3, 2024, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.1444 (Apr 10, 2024), with a median of $0.1167 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 60687080121) is labeled by American Health Packaging, and CMS classifies it as a generic product.